Neurocrine BiosciencesNBIX 
$119.85-2.01%24h
-2.01%24h
Global rank1381
Market cap$11.78B
Change 7d-2.49%
YTD Performance-7.95%
SP500 benchmarkUnderperform
P/E0
P/S6.24
Revenue$1.89B
Earnings$249.70M
Dividend yield-
Main Sector
Healthcare
EPS for Neurocrine Biosciences (NBIX)
Neurocrine Biosciences has an EPS of $1.56. In 2021, the company made an earnings per share (EPS) of $0.92. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for NBIX
-
Value:-
EPS history for Neurocrine Biosciences from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | $1.56 | 69.57% |
| 2021 | $0.92 | -77.88% |
| 2020 | $4.16 | - |
View the highest EPS stocks
